• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:张景双,夏玉平,黄颖华,辜炜君,曹凤玲,殷爱华,郭妹.奥氮平所致药物不良反应的发生率及相关影响因素研究[J].中国现代应用药学,2020,37(11):1375-1379.
ZHANG Jingshuang,XIA Yuping,HUANG Yinghua,GU Weijun,CAO Fengling,YIN Aihua,GUO Mei.Research on the Incidence of Adverse Drug Reactions and Related Influencing Factors Caused by Olanzapine[J].Chin J Mod Appl Pharm(中国现代应用药学),2020,37(11):1375-1379.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1759次   下载 923 本文二维码信息
码上扫一扫!
分享到: 微信 更多
奥氮平所致药物不良反应的发生率及相关影响因素研究
张景双, 夏玉平, 黄颖华, 辜炜君, 曹凤玲, 殷爱华, 郭妹
厦门市精神卫生中心/厦门市仙岳医院, 福建 厦门 361012
摘要:
目的 调查奥氮平所致药物不良反应(adverse drug reactions,ADRs)的发生情况,并探讨其影响因素。方法 选取厦门市精神卫生中心接受治疗的1 691例精神障碍患者,监测治疗过程中奥氮平ADRs的发生情况,采取单因素和多因素分析方法,研究奥氮平ADRs发生的相关影响因素。结果 奥氮平ADRs发生率较高,为33.83%。多因素非条件Logistic回归分析发现有肝病史、服用高剂量药物(>10mg)是奥氮平所致ADRs发生的危险因素,OR值分别为1.824(95% CI:1.155~2.882)和4.910(95% CI:3.943~6.113)。结论 有肝病史及服用高剂量药物(>10 mg)的精神疾病患者是奥氮平ADRs发生的高危人群。
关键词:  奥氮平  不良反应  多因素分析  危险因素
DOI:10.13748/j.cnki.issn1007-7693.2020.11.017
分类号:R969.4
基金项目:
Research on the Incidence of Adverse Drug Reactions and Related Influencing Factors Caused by Olanzapine
ZHANG Jingshuang, XIA Yuping, HUANG Yinghua, GU Weijun, CAO Fengling, YIN Aihua, GUO Mei
Xiamen Mental Health Center/Xiamen Xianyue Hospital, Xiamen 361012, China
Abstract:
OBJECTIVE To investigate the occurrence of adverse drug reactions(ADRs) caused by olanzapine, and then explore its influencing factors. METHODS A total of 1 691 patients with mental disorders treated in Xiamen Mental Health Center were selected to monitor the occurrence of olanzapine ADRs in the treatment process, and the related influencing factors of olanzapine ADRs were studied by single-factor and multi-factor analysis. RESULTS Olanzapine had a higher incidence of ADRs(33.83%). Patients with liver disease history and taking high-dose drugs(>10 mg) were risk factors for ADRs through multivariate unconditional Logistic regression analysis, and the OR values were 1.824(95% CI:1.155-2.882) and 4.910(95% CI:3.943-6.113), respectively. CONCLUSION Patients with liver disease history and high dose of drugs(> 10 mg) are the high-risk groups for ADRs induced by olanzapine.
Key words:  olanzapine  adverse reactions  multivariate analysis  risk factors
扫一扫关注本刊微信